Equity Details
Price & Market Data
Price: $0.402
Daily Change: +$0.0118 / 2.94%
Daily Range: $0.39 - $0.45
Market Cap: $988,390
Daily Volume: 3,648
Performance Metrics
1 Week: -33.38%
1 Month: 11.33%
3 Months: 159.8%
6 Months: -55.10%
1 Year: 55.88%
YTD: -48.04%
About Avenue Therapeutics, Inc. (ATXI)
Essential market details for Avenue Therapeutics, Inc. (ATXI). Current price: 0.402, daily change: +$0.0118 / 2.94%. Market cap: 988,390. Dive into YTD, 1-week, and 6-month performance.
Company Details
Employees: 1
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.